In the July 28th release covering the second quarter of Fiscal 2020, Merck provided sales data for the Animal Health segment. For the second quarter of FY 2022 ending June 30th sales amounted to $1,467 million. This corresponded to $1,472 million during the first quarter of FY 2021 but was apparently five percent higher excluding the effect of foreign exchange. Animal Health sales for Q2 2022 represented 10.1 percent of total company revenue down from 12.9 percent for the corresponding second quarter of FY 2021.

Sales of animal health products for livestock during the most recent quarter attained 56 percent of the segment total with the proportion unchanged from 2021.